Pyrazolo-pyridinone and pyrazolopyrazinone compounds as P38 modulators, process for their preparation, and their pharmaceutical use

Details for Australian Patent Application No. 2008248296 (hide)

Owner Amgen Inc.

Inventors Xu, Shimin; Wurz, Ryan; Pettus, Liping H.; Tasker, Andrew

Agent Shelston IP

Pub. Number AU-B-2008248296

PCT Pub. Number WO2008/136948

Priority 60/928,155 07.05.07 US

Filing date 24 April 2008

Wipo publication date 13 November 2008

Acceptance publication date 1 December 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

19 November 2009 PCT application entered the National Phase

  PCT publication WO2008/136948 Priority application(s): WO2008/136948

1 December 2011 Application Accepted

  Published as AU-B-2008248296

29 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008248319-Methods for differentiating pancreatic cancer from normal pancreatic function and/or chronic pancreatitis

2008248294-Making co-precipitated mixed oxide-treated titanium dioxide pigments